Skip to main content

Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV.

Kipfer ET, Schon J, Chami M, Finke S, Beer M, Hoffmann D, Otte F, Hauser D
iScience. 2026 Sep 16;29(10):117521. doi: 10.1016/j.isci.2026.117521. eCollection 2026 Oct 16. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
253142pcDNA3.1 CMV-SSARS-CoV-2 Wuhan Spike, CMV-driven expression plasmid
253156pcDNA3.1 CMV-F DS-Cav1 ΔCTRespiratory syncytial virus (RSV) F glycoprotein, stabilized in pre-fusion conFormation, DS-Cav1 deltaCT; CMV-driven expression plasmid
253181pcDNA3.1 CMV-esxAMycobactrium tuberculosis esxA; CMV-driven expression plasmid

Antibodies from Article